Structure Therapeutics to Present at Jefferies Healthcare Conference
May 31, 2023 16:30 ET
|
Structure Therapeutics Inc.
SAN FRANCISCO and SHANGHAI, May 31, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule...
The India Edible Oil (Soybean, Palm, Cottonseed, Ground Nut, Sunflower, Sesame, Mustard, Coconut, Rice brand, Corn, Olive and Others) Market to reach INR 529639.18 Crore by 2027-28. – Bonafide Research
May 30, 2023 02:08 ET
|
Bonafide Research & Marketing Pvt. Ltd.
Clifton, New Jersey, May 30, 2023 (GLOBE NEWSWIRE) -- India is blessed with many positive factors that enable it to stand in a unique position in Agro-based products. After achieving independence,...
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity
May 25, 2023 16:30 ET
|
Structure Therapeutics Inc.
12-week Phase 2a and Phase 1b multiple ascending dose (MAD) topline results expected to be announced in latter half of fourth quarter 2023 Ethnobridging study initiated in Japanese individuals and...
$7.92 Bn Direct-to-consumer (DTC) Laboratory Testing Markets: Genetic Testing {Ancestry, Carrier Status, Disease Risk}, Diabetes, COVID, STD, Routine, CBC - Global Forecast to 2030
May 19, 2023 09:43 ET
|
Research and Markets
Dublin, May 19, 2023 (GLOBE NEWSWIRE) -- The "Direct-to-consumer (DTC) Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological,...
Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference
May 18, 2023 16:30 ET
|
Structure Therapeutics Inc.
SAN FRANCISCO and SHANGHAI, China, May 18, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule...
Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
May 11, 2023 16:30 ET
|
Structure Therapeutics Inc.
Oral GLP-1 agonist GSBR-1290 advancing into Phase 2a study in type 2 diabetes and obesity Topline data from Phase 1b multiple ascending dose and Phase 2a studies of GSBR-1290 expected in second half...
Global Hyper-Personalized Medicine Market Expected to Generate a Revenue of $5,886.50 Billion and Rise at a CAGR of 11.7% over the 2022-2031 Timeframe [280-Pages] | Information by Research Dive
May 10, 2023 09:05 ET
|
Research Dive
New York, USA, May 10, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global hyper-personalized medicine market is anticipated to garner a revenue of $5,886.50...
The Home Infusion Therapy Market is Projected To Reach USD 61.7 billion By 2030, From USD 31.94 billion in 2022,Registering a CAGR Of 7.90% During The Forecast Period 2023-2030| Data By Contrive Datum Insights Pvt Ltd.
May 09, 2023 09:09 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, May 09, 2023 (GLOBE NEWSWIRE) -- The Global Home Infusion Therapy Market size was valued at USD 31.94 billion in 2022 and is projected to reach USD 61.7 billion by 2030, growing at a...
Urinary Catheters Market Value to expand at a 4.5% CAGR from 2021 to 2028, reaching USD 5.1 billion: TMR Report
May 05, 2023 14:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 06, 2023 (GLOBE NEWSWIRE) -- The global urinary catheters market was estimated at a market value of USD 3.1 billion in 2020. During the forecast years of...
Urinalysis Market is Expected to Reach $5.7 billion | MarketsandMarkets.
May 04, 2023 09:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 04, 2023 (GLOBE NEWSWIRE) -- The urinalysis industry is an important segment of the diagnostic testing market, focused on analyzing urine samples to diagnose and monitor various medical...